Medical devices, healthcare technology and the business of care
510(k) clearance · K260391

AVIEW Aorta Metrics

Coreline Soft Co., Ltd. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONK260391

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision for AVIEW Aorta Metrics, submitted by Coreline Soft Co., Ltd. of Seoul, KR, under 510(k) number K260391. The decision date is 2026-10-16; the application was received 02/06/2026. The device falls under regulation 892.1750, classification product code JAK, in the Radiology specialty and review panel, as a Traditional 510(k) not reviewed by a third party. SESE denotes clearance rather than PMA approval.

The public record identifies the device classification name as System, X-Ray, Tomography, Computed, and lists no combination product and no authorized Predetermined Change Control Plan. The source does not include a summary statement or describe the specific components, intended use, or any changed item, so the technical scope of this clearance remains unknown from the provided material. No clinical, efficacy, or patient-selection conclusions are drawn here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260391
Regulatory pathway
510(k) premarket notification
Product code
JAK
Decision code
SESE
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, X-Ray, Tomography, Computed.

Product code
JAK
FDA device class
2

FDA decision timeline

  1. K260391 received

    Application receipt date recorded by FDA.

  2. K260391 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code JAK

Product / regulatory recordCompanyPathwayDecision dateSource
CAS-One IRK261225
Cascination AG510(k) clearanceSep 29, 2026FDA
Samsung HME America, Inc., dba NeuroLogica Corp.510(k) clearanceSep 22, 2026FDA
Fujifilm Corporation510(k) clearanceSep 18, 2026FDA
Fujifilm Corporation510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Coreline Soft Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Seoul

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records